设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 5 期 第 16 卷

健脾益肾举陷汤联合西药治疗重症肌无力临床研究

Clinical study on the treatment of myasthenia gravis with Jianpi Yishen Juxian decoction combined with western medicine

作者:魏东生罗利俊杨洁丁君

英文作者:Wei Dongsheng Luo Lijun Yang Jie Ding Jun

单位:武汉市第一医院武汉市中西医结合医院神经内科430022

英文单位:Department of Neurology Wuhan No.1 Hospital Wuhan Hospital of Traditional Chinese and Western Medicine Wuhan 430022 China

关键词:重症肌无力;健脾益肾举陷汤;西药

英文关键词:Myastheniagravis;JianpiYishenJuxiandecoction;Westernmedicine

  • 摘要:
  • 目的 探讨健脾益肾举陷汤联合西药治疗重症肌无力(MG)的临床效果。方法 选取武汉市中西医结合医院神经内科20173月至20196月收治的75MG患者(全身型),按照随机数字表法分为对照组(35例)和观察组(40例)。对照组采用常规西药治疗,观察组采用健脾益肾举陷汤联合西药治疗。比较2组临床疗效,治疗前后免疫指标水平,徒手肌力评定(MMT)、日常生活活动能力量表(ADL)、美国 MG 基金会(MGFA)疾病严重程度评价量表评分,乙酰胆碱受体抗体(AchR-Ab)水平及不良反应发生率。结果 观察组总有效率明显高于对照组[95.0%38/40)比80.0%28/35)](P0.05)。治疗后,2组免疫球蛋白(IgMIgG水平均明显高于治疗前,且观察组均明显高于对照组[(1.43±0.43g/L比(1.14±0.21g/L、(12.3±1.3g/L比(8.3±1.6g/L](均P0.05)。治疗后,2MMT评分、ADL评分及MGFA疾病严重程度评价量表评分均明显低于治疗前,且观察组均明显低于对照组[(11±4)分比(21±4)分、(2.9±0.6)分比(5.5±0.9)分、(7.9±1.6)分比(11.1±2.3)分](均P0.05)。治疗后,2AchR-Ab水平均明显低于治疗前,且观察组明显低于对照组[(1.62±0.25nmol/L比(2.02±0.31nmol/L](均P0.05)。2组不良反应发生率比较,差异无统计学意义(P0.05)。结论 健脾益肾举陷汤联合西药治疗MG可有效提高临床疗效,缓解肌无力等症状,降低AchR-Ab 水平,提高生活能力,调节免疫功能,且安全性较好。

  • Objective To investigate the clinical effect of Jianpi Yishen Juxian decoction combined with western medicine on myasthenia gravis (MG). Methods From March 2017 to June 2019, 75 MG patients (systemic type) admitted to the Department of Neurology, Wuhan Hospital of Traditional Chinese and Western Medicine were selected. They were randomly divided into the control group (35 cases) and the observation group (40 cases). The control group was treated with conventional western medicine, and the observation group was treated with Jianpi Yishen Juxian decoction combined with western medicine. The clinical efficacy, immune indexes level, manual muscle test (MMT), activities of daily living scale (ADL), MG Foundation of America (MGFA) disease severity assessment scale scores, the level of acetylcholine receptor antibody (AchR-Ab) and the incidence of complications were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group 95.0%(38/40) vs 80.0%(28/35)(P0.05). After treatment, immunoglobulin(Ig) M and IgG levels in the two groups were significantly higher than those before treatment, and those in the observation group were significantly higher than those in the control group[(1.43±0.43g/L vs 1.14±0.21g/L,12.3±1.3g/L vs 8.3±1.6g/L(all P0.05). After treatment, MMT score, ADL score and MGFA disease severity assessment scale score of the two groups were significantly lower than those before treatment, and those in the observation group were significantly lower than those in the control group[(11±4 vs 21±4, 2.9±0.6 vs 5.5±0.9, 7.9±1.6 vs 11.1±2.3)](all P0.05). After treatment, the levels of AchR-Ab in both groups were significantly lower than that before treatment, and that in the observation group was significantly lower than that in the control group[(1.62±0.25nmol/L vs 2.02±0.31nmol/L(all P0.05). There was no significant difference in the incidence of complications between the two groups (P0.05). Conclusion The treatment of MG with Jianpi Yishen Juxian decoction combined with western medicine can effectively improve the clinical efficacy, relieve myasthenia and other symptoms, reduce AchR-Ab level, improve living ability, and regulate immune function with good safety.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭